© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
January 16, 2021
See what ranked most popular in our top 10 stories of 2020.
January 14, 2021
Amid ramped up production of vaccines, CARES Act gives FDA power to head off potential drug shortfalls. Prevent Blindness is urging the FDA to use its authority to ensure TED treatment drug supply isn’t interrupted.
January 13, 2021
From patient care and treating glaucoma to the ongoing pandemic, ophthalmologists share the most pressing thoughts of concern leaving them awake at night.
January 12, 2021
Delivery into the suprachoroidal space may potentially extend the duration of therapeutic action and reduce or relieve the treatment burden for wet AMD.
January 11, 2021
Amydis announced the successful completion of a pre-investigational new drug (IND) meeting with the FDA for its candidate AMDX-2011P, a small-molecule retinal tracer that targets amyloid beta to diagnosis amyloid angiopathy.
January 11, 2021
In a letter to Health and Human Services Secretary Alex Azar, the American Hospital Association is urging the federal government to expedite the administration of COVID-19 vaccines.
January 10, 2021
Two teams of researchers from Gyroscope Therapeutics and the University of Pennsylvania are joining forces to explore gene therapy targets for three specific serious eye diseases.
January 09, 2021
Cynthia Matossian, MD, FACS, ABES, discusses the big disconnect between signs and symptoms of ocular surface disease, including meibomian gland dysfunction, and why a clear process for educating patients and initiating treatment is essential.
January 08, 2021
Tamara R. Fountain, MD, will serve as president of the American Academy of Ophthalmology after being elected by the organization’s community of ophthalmologists during its recent virtual annual meeting.
January 07, 2021
Topline data following completion of ALTISSIMO trial treatment phase expected in second quarter of 2021.
